Ameluz® and RhodoLED® New Drug Application (NDA) and Investigational New Drug Application (IND) have successfully been transferred to ...

Conventional pancreatic cancer treatments face a critical hurdle due to the dense tumor microenvironment (TME). This ...

Last patient completed 1 year follow-up of study ALA-BCC-CT013 in December 2024. Data from follow-up will be included in FDA submission, expected in Q3 2025. Biofrontera announced highly statistically ...

Photodynamic Therapy (PDT) devices are medical instruments used in photodynamic therapy, a treatment that utilizes light-activated drugs (photosensitizers) to target and destroy abnormal cells. PDT is ...

Detailed price information for Biofrontera Inc (BFRI-Q) from The Globe and Mail including charting and trades.

WOBURN, MA / ACCESSWIRE / June 1, 2023 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatologic products, ...

This trial was looking at whether photodynamic therapy alongside surgery is helpful for people who have just been diagnosed with a type of brain tumour called glioblastoma multiforme (GBM).

Analysis of four human PlGF isoforms and of VEGFR-1 in esophageal carcinoma. Background: FDA approved PDT with porfimer sodium has been explored to treat lesions associated with Barrett's esophagus.

Three decades after the term photodynamic therapy (PDT) was coined, and several more since the basic principles behind it were first outlined, the technique remains characterized by promise rather ...

Research groups of Professors Weiqi Zhang, Haiyan Xu and Lin Wang from the Institute of Basic Medical Sciences, Chinese ...

Central serous chorioretinopathy (CSCR) is an idiopathic disorder characterised by detachment of the neurosensory retina due to serous fluid accumulation between the photoreceptor outer segments and ...